Modeling Alcohol Self-Administration in the Human Laboratory
This review focuses on 27 studies employing experimental alcohol self-administration (ASA) in humans which were published between 1989 and 2010. Twelve studies enrolling healthy, non-dependent social drinkers (HSD) were aimed at evaluating physiological and behavioral determinants of alcohol-induced reward or modeling situations of increased risk to develop alcohol use disorders. The remaining 15 studies tested the effect of medications such as naltrexone, nalmefene, nicotine, mecamylamine, varenicline, gabapentin, aripiprazole, and rimonabant on ASA. The participants were either HSD or non-treatment-seeking alcoholics (NTSA). In 25 of these studies, the subjects ingested alcohol orally and reached a mean peak blood alcohol concentration (BAC) during baseline conditions between 43 and 47 mg% (0.043–0.047%). Two recent studies employed computer-assisted self-infusion of ethanol (CASE), where subjects press a button to request multiple sequential alcohol exposures intravenously instead of drinking. This method has been demonstrated to be safe and provides increased experimental control of BAC and keeps subjects blind concerning the amount already self-administered. Peak exposures in the CASE studies ranged from 60 to 80 mg% in HSD and up to 240 mg% in NTSA.
KeywordsAlcohol Self-administration Human Alcohol dependence
This work was supported by the following grants and institutions: P60 AA007611-20
U01 AA017900-01 (S.OC. and U.S.Z).
Division of Intramural Clinical and Biological Research, NIAAA, NIH (V.A.R).
- Bigelow G, Liebson I (1972) Cost factors controlling alcoholic drinking. The Psychol Rec 22:305–314Google Scholar
- Enoch MA, Johnson K, George DT, Schumann G, Moss HB, Kranzler HR, Goldman D (2009) Ethical considerations for administering alcohol or alcohol cues to treatment-seeking alcoholics in a research setting: can the benefits to society outweigh the risks to the individual? A commentary in the context of the National Advisory Council on Alcohol Abuse and Alcoholism–Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation (2005). Alcohol Clin Exp Res 33:1508–1512PubMedCentralPubMedCrossRefGoogle Scholar
- George DT, Herion DW, Jones CL, Phillips MJ, Hersh J, Hill D, Heilig M, Ramchandani VA, Geyer C, Spero DE, Singley ED, O’Malley SS, Bishai R, Rawlings RR, Kunos G (2010) Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers. Psychopharmacology (Berl) 208:37–44CrossRefGoogle Scholar
- National Advisory Council on Alcohol Abuse and Alcoholism (2005) Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation. http://www.niaaa.nih.gov/Resources/ResearchResources/job22.htm, last accessed on 10 Jun 2011
- Plawecki MH, Han JJ, Doerschuk PC, Ramchandani VA, O’Connor S (2008) A physiologically-based pharmacokinetic (PBPK) model for alcohol: mathematical foundations. IEEE Trans Biomed Eng 55:2691–2700Google Scholar
- Ramchandani VA, Umhau J, Pavon FJ, Ruiz-Velasco V, Margas W, Sun H, Damadzic R, Eskay R, Schoor M, Thorsell A, Schwandt ML, Sommer WH, George DT, Parsons LH, Herscovitch P, Hommer D, Heilig M (2010) A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry. doi: 10.1038/mp.2010.56
- Zimmermann US, Mick I, Laucht M, Vitvitskiy V, Plawecki MH, Mann KF, O’Connor S (2009) Offspring of parents with an alcohol use disorder prefer higher levels of brain alcohol exposure in experiments involving computer-assisted self-infusion of ethanol (CASE). Psychopharmacology (Berl) 202:689–697CrossRefGoogle Scholar